Management Team

Elina Haavisto

MSc, Head of CMC Regulatory Affairs

Head of CMC Regulatory Affairs, Elina Haavisto, has over a decade’s experience of clinical and industrial experience in oncolytic adenoviruses. Elina has worked at Oncos Therapeutics Ltd. (now Targovax ASA), and has broad experience in CMC, regulatory and adenovirus GMP manufacturing. Elina is responsible for the management of the outsourced virus manufacturing and logistics with the clinical trial sites, as well as preparation of CMC regulatory documentation.

Akseli Hemminki

MD, PhD, eMBA, Founder & CEO and Chairman of the Board

Aino Kalervo

MSc, MS, Chief Business Officer

Kari Varkila

MD, PhD, MBA, Chief Medical Officer

Tuija Keinonen

PhD, Chief Regulatory Officer

Claudia Kistler

PhD, Head of Clinical Operations

Víctor Cervera-Carrascón

M.Pharm, Head of Immunology

Riikka Havunen

PhD, Head of R&D

Riikka Kalliokoski

Bachelor of Social and Health Care, Lab manager

João Manuel Santos

MSc, Head of Cell Therapy

no image

Suvi Sorsa

PhD, Head of Clinical Research

Remi Gloeckler

PhD, CMC Advisor